Kana Miyata

Assistant Professor

Saint Louis University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kana Miyata is an Assistant Professor at Saint Louis University in the United States. His research focuses on kidney disease, transplant outcomes, and the socioeconomic factors influencing treatment disparities. Recent articles authored by Dr. Miyata explore topics including the effects of dapagliflozin in Alport syndrome and the economic impact of dementia post-kidney transplantation.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Bahar Bastani

Saint Louis University School of Medicine

UNITED STATES

View details

Michifumi Yamashita

Assistant Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Jeffrey Miner

Professor

Washington University in St. Louis

UNITED STATES

View details

János G. Filep

Université de Montréal

CANADA

View details

Ngan N. Lam

University of Calgary

CANADA

View details

Faith Andrea Yeargin

University of Louisville

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kana Miyata

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome

Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records

Untangling genetic and environmental risks in kidney transplant outcomes: The interplay of self-identified race, genetic ancestry, monogenic risk alleles, and socioeconomic factors

“I Feel My Catheter Moving Around”: A clue for the diagnosis of late pregnancy while on peritoneal dialysis

Implications of Incomplete Immunostaining in Membranous Lupus Nephritis

Fibrillary glomerulonephritis diagnosed by an immunostaining for DNA‐J heat‐shock protein family member B9

Factitious Hypobicarbonatemia in a Patient with Hypertriglyceridemia

A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus

Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice

Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes

Hematuria and Flank Pain in a Patient with Sickle Cell Trait Who Is Taking NSAIDs

Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium–Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice

Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice.

The Rationale and Evidence for SGLT2 Inhibitors as a Treatment for Nondiabetic Glomerular Disease

Comparison of the effects of insulin and SGLT2 inhibitor on the Renal Renin-Angiotensin system in type 1 diabetes mice

Collaborators (6)

Bahar Bastani

Michifumi Yamashita

Jeffrey Miner

János G. Filep

Ngan N. Lam

Faith Andrea Yeargin

Make your next move.